Additional Proxy Soliciting Materials (definitive) (defa14a)
August 01 2019 - 4:14PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 30, 2019
CYTRX
CORPORATION
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-15327
|
|
58-1642740
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
11726
San Vicente Boulevard, Suite 650
Los
Angeles, California 90049
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
(310) 826-5648
None
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[X]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth
company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
On
July 30, 2019, CytRx Corporation (the “
Company
”) called to order its 2019 Annual Meeting of Stockholders
(the “
Annual Meeting
”), which was adjourned for lack of a quorum to conduct formal business. The Annual
Meeting was adjourned until 10:00 a.m., Pacific Time, on August 29, 2019, to be held at 10100 Santa Monica Blvd., Lobby
Conference Center, Ground Floor, Los Angeles, CA 90067.
During
the period of the adjournment, the Company will continue to solicit proxies from its stockholders with respect to the proposals
set forth in the Company’s Proxy Statement dated June 26, 2019. Stockholders who have previously submitted their proxy and
do not want to change their vote do not need to take any action. The Company encourages all stockholders who have not yet voted
to do so before August 29, 2019.
No
changes have been made in the proposals to be voted on by stockholders at the Annual Meeting. The Company’s proxy statement
and any other materials filed by the Company with the SEC remain unchanged and can be obtained free of charge at the SEC’s
website at
www.sec.gov
.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CYTRX
CORPORATION
|
|
|
Date:
August 1, 2019
|
/s/
John Y. Caloz
|
|
John
Y. Caloz
|
|
Chief
Financial Officer
|
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From Feb 2025 to Mar 2025
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From Mar 2024 to Mar 2025